Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
Roche’s $7.1bn Acquisition of Roivant from Pfizer
SERB Pharmaceuticals’ Partnership with SFJ Pharmaceuticals
Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...
Berkeley Lights’ Acquisition of IsoPlexis
Freshfields advised Berkeley Lights on the deal, while Cravath represented IsoPlexis. Berkeley Lights (Nadsaq: BLI), a life sciences tools company, acquired IsoPlexis (Nasdaq: ISO), a company...
Sairopa’s Collaboration, Option and License Agreement With Exelixis
Freshfields advised Sairopa on the deal. Sairopa, a clinical-stage company that develops novel treatments for cancer by modulating the patient’s immune system, signed a collaboration and...
Ginkgo Bioworks’ Acquisition of Zymergen Inc.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
KPS Capital’s $2.7 Billion Acquisition of EMEA Packaging Business
Cuatrecasas and Paul, Weiss, Rifkind, Wharton & Garrison advised KPS Capital Partners on the deal. Leading global private equity firm, KPS Capital Partners, finalized the acquisition of the...
MET Group’s Acquisition of Cogen Energia From Arendals Fossekompani
CLP and Gómez-Acebo & Pombo advised Arendals Fossekompani ASA, while Cuatrecasas has advised the MET Group on the deal. Arendals Fossekompani has entered into an agreement with...